ClinicalTrials.gov
ClinicalTrials.gov Menu

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01096602
Recruitment Status : Active, not recruiting
First Posted : March 31, 2010
Last Update Posted : May 11, 2018
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Medivation, Inc.
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Jacalyn Rosenblatt, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : June 2024